Who Paid My Doc
clonoSEQ
Device Oncology
General payments
$933,993
Research payments
$1,523,700
Through program year 2024, $933,993 in general payments and $1,523,700 in research payments were reported against clonoSEQ (Oncology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $462,295 | 3,663 |
| 2024 | Research | $952,650 | 435 |
| 2023 | General | $471,698 | 3,098 |
| 2023 | Research | $571,050 | 475 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 58 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 47 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
6,761 general · 910 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.